Skip to content
etf.net

CURE vs FAS

Direxion Daily Healthcare Bull 3X ETF

CUREANYSE Arca

Direxion Daily Financial Bull 3X ETF

FASANYSE Arca

Overlap

Expense ratio

FAS −0.06pt a year

CURE0.94%FAS0.88%

Avg volume · 30D

FAS 6.4×the volume

CURE64.4KFAS413K

10Y return · a year

CURE +0.6pt

CURE+21.5%FAS+20.9%

CURE vs FAS Performance

Oct 29, 2021 – Oct 30, 2026

+43.1%CURE+31.4%FAS

Oct 29, 2021 to Oct 30, 2026. CURE +43.1%. FAS +31.4%. Use the arrow keys to read each point.−60%−40%−20%0%Oct 2021Apr 2024Oct 2026
Expense ratio
CURE 0.94%
FAS 0.88%, better
Fund size
CURE $199M
FAS $2.17B
1Y total return
CURE +84.6%, better
FAS +12.3%
Yield (12M)
CURE 0.75%
FAS 8.87%, better
Holdings
CURE 67
FAS 87
Avg volume (30D)
CURE 64.4K sh
FAS 413K sh, better
NAV per share
CURE $165.72
FAS $168.18
52W range

ETF.net Grade

CURE: Cost 78, Risk 75, Mission not scored, Tradability 58, Holdings not scored, Durability 53. FAS: Cost 92, Risk 69, Mission not scored, Tradability 73, Holdings not scored, Durability 66.
Pillar letters and Scores for CURE, FAS, with each pillar’s weight
PillarCUREFAS
Cost30% weightA78A92Higher
Mission25% weightNot scoredNot scored
Risk15% weightA75HigherB69
Tradability15% weightB58A73Higher
Holdings10% weightNot scoredNot scored
Durability5% weightC53B66Higher

Rank among 3x Leveraged Long funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. CURE and FAS are both graded against the same 30 3x Leveraged Long funds, so their Grades compare head to head.

3x Leveraged Long⁠

Category · 30 funds
See all 30 ›

FAS ranks 3rd and CURE 7th of 30 funds in the 3x Leveraged Long Category.

  1. Rank 1ATQQQProShares UltraPro QQQScore 86
  2. Rank 2AUDOWProShares UltraPro Dow30Score 81
  3. Rank 3AFASDirexion Daily Financial Bull 3X ETFScore 80
  4. Rank 4ASOXLDirexion Daily Semiconductor Bull 3X ETFScore 76
  5. Rank 6ATECLDirexion Daily Technology Bull 3X ETFScore 72
  6. Rank 7ACUREDirexion Daily Healthcare Bull 3X ETFScore 70
  7. Rank 8BDPSTDirexion Daily Regional Banks Bull 3X ETFScore 68

Our read on each fund

ETF.net Research

CUREADirexion Daily Healthcare Bull 3X ETF

FASADirexion Daily Financial Bull 3X ETF

In short

CURE Healthcare is the market's defensive sector. CURE straps three-times daily leverage to it, aiming for 300% of the Health Care Select Sector Index's daily move across drugmakers, insurers and device names. A trading tool with a one-day clock, running since 2011.

FAS Born in November 2008 with the banking system on fire, FAS aims to deliver three times the daily move of the Financial Select Sector Index. A one-day tool on roughly 80 financial stocks, built around a single-day objective.

Stated mandate

CURE The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the Health Care Select Sector Index.

FAS The fund seeks a daily return equal to three times the performance of the Financial Select Sector Index, before fees and expenses. It is designed for a single-day objective rather than a multiple of the index’s cumulative return over longer periods.

Why people hold it

  • CURE Fee is 0.94%, below what the typical leveraged bull fund charges. On a geared product you rent by the day, that gap is real money.
  • One job, plainly stated: 300% of the daily performance of the Health Care Select Sector Index, roughly 70 large-cap US healthcare names. No stock picking, no style drift.direxion.com
  • Trading since 2011, a long tenure for a geared sector fund, and one of the stronger builds among leveraged bull ETFs.
  • FAS Launched in November 2008, into the crisis itself, and still one of the strongest implementations in its 3x peer group.
  • Costs 0.88% net of a waiver through September 1, 2027 (0.92% gross), below the median for 3x leveraged funds.
  • A multi-billion-dollar fund that trades steadily, so the leverage arrives in a reasonably liquid wrapper.
  • Straightforward plumbing: 3x the daily move of one named large-cap financials index, about 80 stocks, no stock-picking overlay.

Worth knowing

  • CURE The leverage resets every day. Hold past the closing bell and compounding takes over, so multi-day results can land far from 3x the index over that stretch.
  • Gearing is symmetrical. A bad day for healthcare, drug-pricing headlines or an FDA surprise, comes through roughly tripled.
  • One sector, about 70 stocks, then leverage on top. Concentration and gearing stack, so daily swings dwarf a broad-market fund's.
  • FAS The 3x goal resets every day. Hold longer and compounding can push results away from three times the index's move over that stretch, especially in choppy markets.
  • Leverage runs both directions: down days are magnified just as sharply, and this is one sector in one direction with no diversification cushion.
  • Not the cheapest 3x on the shelf: SOXL runs 0.75% and TQQQ 0.78%, each net of waivers through September 1, 2027 and September 30, 2027.

Full CURE profile⁠

Full FAS profile⁠

CURE vs FAS Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

CURE vs FAS Cost

Overpaying CURE vs FAS

$999

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • CURE 0.94%

    $17,704

  • FAS 0.88%

    $16,705

$10,000
30 years

Cost over time

  • CURE 0.94%
  • FAS 0.88%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530CURE $17,704FAS $16,705

Year by year

YearCUREFASOverpaying
10$1,661$1,559$102
20$6,260$5,891$369
30$17,704$16,705$999

Expense ratio

  • 0.94%CURE
  • 0.88%FAS, cheaper
  • Middle half of 3x Leveraged Long funds
  • Median 0.96%

FAS 4th cheapest of 30 funds

CURE 7th cheapest of 30 funds

CURE vs FAS Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
CURE 0.75%
FAS 8.87%, better
Payout (12M)
CURE $1.26
FAS $14.62
Last payment
CURE $0.32
FAS $1.00
Ex-dividend
CURE Sep 22, 2026
FAS Sep 22, 2026
Paid on
CURE Sep 29, 2026
FAS Sep 29, 2026
Frequency
CURE Quarterly
FAS Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

CUREQuarterly · 32 paymentsAll CURE payments⁠
One bar per payment. 32 payments from 2017 to 2026 YTD. Dec 13, 2017 $0.02; Dec 19, 2017 $0.07; Jun 19, 2018 $0.11; Sep 25, 2018 $0.09; Dec 27, 2018 $0.14; Mar 19, 2019 $0.09; Sep 24, 2019 $0.20; Dec 23, 2019 $0.00006; Mar 24, 2020 $0.10; Jun 23, 2020 $0.02; Sep 22, 2020 $0.01; Dec 22, 2020 $0.0061; Dec 21, 2021 $0.03; Mar 22, 2022 $0.04; Jun 22, 2022 $0.08; Sep 20, 2022 $0.18; Dec 20, 2022 $0.14; Mar 21, 2023 $0.49; Jun 21, 2023 $0.54; Sep 19, 2023 $0.45; Dec 21, 2023 $0.57; Mar 19, 2024 $0.36; Jun 25, 2024 $0.27; Sep 24, 2024 $0.33; Dec 23, 2024 $0.12; Mar 25, 2025 $0.35; Jun 24, 2025 $0.31; Sep 23, 2025 $0.31; Dec 23, 2025 $0.29; Mar 24, 2026 $0.28; Jun 23, 2026 $0.37; Sep 22, 2026 $0.32. Use the arrow keys to read each point.$0$102017202020232026YTD
FASQuarterly · 36 paymentsAll FAS payments⁠
One bar per payment. 36 payments from 2017 to 2026 YTD. Dec 19, 2017 $0.08; Mar 20, 2018 $0.13; Jun 19, 2018 $0.16; Sep 25, 2018 $0.19; Dec 27, 2018 $0.16; Mar 19, 2019 $0.16; Jun 25, 2019 $0.17; Sep 24, 2019 $0.15; Dec 23, 2019 $0.11; Mar 24, 2020 $0.12; Jun 23, 2020 $0.04; Sep 22, 2020 $0.05; Dec 22, 2020 $0.08; Mar 23, 2021 $0.13; Jun 22, 2021 $0.14; Sep 21, 2021 $0.15; Dec 21, 2021 $0.36; Jun 22, 2022 $0.12; Sep 20, 2022 $0.22; Dec 20, 2022 $0.33; Mar 21, 2023 $0.17; Jun 21, 2023 $0.62; Sep 19, 2023 $0.29; Dec 21, 2023 $0.38; Mar 19, 2024 $0.36; Jun 25, 2024 $0.27; Sep 24, 2024 $0.32; Dec 23, 2024 $0.19; Mar 25, 2025 $0.46; Jun 24, 2025 $0.50; Sep 23, 2025 $0.39; Dec 10, 2025 $12.09; Dec 23, 2025 $0.39; Mar 24, 2026 $0.60; Jun 23, 2026 $0.53; Sep 22, 2026 $1.00. Use the arrow keys to read each point.$0$102017202020232026YTD

CURE vs FAS Risk

Fall from peak · 5 years

  • CURE
  • FAS
Oct 29, 2021 to Oct 30, 2026. Worst fall: FAS −66.9% · Oct 2023. Use the arrow keys to read each point.−60%−40%−20%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
CURE 44.6%, betterFAS 46.3%
Return per unit of riskSharpe ratio, 3 years
CURE 0.71FAS 1.03, better
Worst fallMax drawdown, 5 years
CURE −52.3%, betterFAS −66.9%
Market sensitivityBeta, 5 years
CURE 1.27FAS 2.63

Popular comparisons

  • CUREAvsTQQQA

    Direxion Daily Healthcare Bull 3X ETF · ProShares UltraPro QQQ

    Expense ratio
    0.94% · 0.78%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • FASAvsTQQQA

    Direxion Daily Financial Bull 3X ETF · ProShares UltraPro QQQ

    Expense ratio
    0.88% · 0.78%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • CUREAvsUDOWA

    Direxion Daily Healthcare Bull 3X ETF · ProShares UltraPro Dow30

    Expense ratio
    0.94% · 0.94%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • FASAvsUDOWA

    Direxion Daily Financial Bull 3X ETF · ProShares UltraPro Dow30

    Expense ratio
    0.88% · 0.94%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • CUREAvsSOXLA

    Direxion Daily Healthcare Bull 3X ETF · Direxion Daily Semiconductor Bull 3X ETF

    Expense ratio
    0.94% · 0.75%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • FASAvsSOXLA

    Direxion Daily Financial Bull 3X ETF · Direxion Daily Semiconductor Bull 3X ETF

    Expense ratio
    0.88% · 0.75%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.